Synaffix.com

Site Inspections

Overview & More informations

Synaffix is a leading provider of biosimilar medicines. The company was founded in 2007 and is headquartered in Toronto, Canada. Synaffix has a global presence with operations in North America, Europe, and Asia. The company's mission is to provide affordable, high-quality biosimilar medicines to patients around the world.

Synaffix's product portfolio includes a range of biosimilar medicines, including:

• Etanercept (Enbrel)


• Adalimumab (Humira)


• Infliximab (Remicade)


• Rituximab (Rituxan)


• Trastuzumab (Herceptin)

Synaffix's biosimilar medicines are manufactured using state-of-the-art technology and meet the same high standards of quality and safety as the original reference products. The company's products are approved by regulatory authorities in a number of countries around the world, including the United States, Canada, Europe, and Japan.

Synaffix is committed to providing affordable biosimilar medicines to patients around the world. The company's products are typically priced at a significant discount to the original reference products, making them more accessible to patients who need them.

Synaffix is a rapidly growing company with a strong track record of success. The company has a number of promising products in its pipeline, and it is well-positioned to continue to grow in the future.

Domains Expiration Date Updated